Skip to main content

Intuitive Surgical Inc

ISRG
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001035267

In the last 90 days, Intuitive Surgical Inc insiders filed 0 open-market purchases and 10 sales; 2,261 institutions reported holding it in 13F filings for Q2 2026, worth $121.9B in total; 3 superinvestors hold it, including Coatue Management and D1 Capital Partners.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Intuitive Surgical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
5 insiders, $4.98M in total
Insiders trading
5
Net value
−$4.98M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Intuitive Surgical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Intuitive Surgical Inc
NameTitleLast reported holdingLast filingFilings, past year
Widman FredrikVP Corporate Controller1,026Sep 16, 20265
Brosius MarkEVP & Chief Mfg and Supply Cha764Sep 11, 202618
Guthart Gary SDirector1,245,679IndirectAug 12, 20269
Ladd Amy LDirector179Aug 11, 20263
Loeb GaryEVP & Chief Legal and Complian5,320Aug 10, 20268
Rosa David J.Chief Executive Officer (CEO)246,856Jul 13, 20268
Jeddi ImanSVP & GM da Vinci Platforms &6,463Jun 2, 20264
Nachtsheim Jami KDirector6,902Apr 30, 20261
Chew LewisDirector1,314Apr 30, 20261
Beery Joseph CDirector3,641Apr 30, 20261
Barratt Craig HDirector27,948IndirectApr 30, 20263
Johnson Amal MDirector13,545Apr 30, 20261
Leonard Keith RDirector901Apr 30, 20263
Kolli SreelakshmiDirector1,510Apr 30, 20261
Reed Monica PDirector2,876Apr 30, 20261
Curet MyriamEVP & Chief Medical Officer0Mar 11, 202611
Samath JamieEVP & CFO & Enterprise Technol15,366Mar 2, 20264
Charlton Henry LEVP & Chief Commercial and Mkt11,610Mar 2, 20265
Wadors Patricia LSVP Chief Human Resources Offi0Feb 27, 20261
Miller Brian EdwardEVP & Chief Digital Officer5,758Nov 12, 20251
DeSantis RobertEVP & Chief Strategy & Corp Op5,224Apr 29, 20250
Rubash Mark JDirector16,790Apr 25, 20250
Mohr MarshallExecutive VP Global Business S1,650Sep 3, 20240
Kania Don RDirector3,838Apr 26, 20240
Levy Alan JDirector25,888Apr 26, 20240
DiMartino MicheleSee Remarks2,112Mar 1, 20230
Andersen Reiter KaraSr VP General Counsel & CCO18,067Aug 30, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 26, 2021 (view filing)Jul 233 daysLevy Alan JDirectorSSale−2.50K$967.36−$2.42M−23.6%8.09K after2 lots
Jul 26, 2021 (view filing)Jul 233 daysLadd Amy LDirectorSSale−128$971.64−$124.4K−33.4%255 after
Jul 26, 2021 (view filing)Jul 233 daysBarratt Craig HDirectorSSale−1.27K$967.20−$1.23M−100.0%0 after
Jul 26, 2021 (view filing)Jul 233 daysSamath JamieSVP of FinanceSSale−503$971.64−$488.7K−66.5%253 after6 lots
Jul 26, 2021 (view filing)Jul 233 daysDeSantis RobertEVP & Chief Product OfficerSSale−4.00K$967.27−$3.87M−91.7%363 after4 lots
Jul 27, 2021 (view filing)Jul 261 dayMohr MarshallExecutive VP & CFOSSale−6.83K$963.38−$6.58M−100.0%0 after
Aug 3, 2021 (view filing)Aug 3Same dayLeonard Keith RDirectorSSale−996$1,000.00−$996.0K−54.0%849 after
Aug 9, 2021 (view filing)Aug 5-64 daysRosa David J.EVP & Chief Business OfficerSSale−16.2K$1,009.55−$16.4M−30.2%37.5K after2 lots
Aug 12, 2021 (view filing)Aug 111 dayJohnson Amal MDirectorSSale−2.50K$1,001.63−$2.50M−40.2%3.72K after
Aug 27, 2021 (view filing)Aug 261 dayDeSantis RobertEVP & Chief Product OfficerSSale−397$1,048.12−$416.1K−52.2%364 after
Sep 10, 2021 (view filing)Sep 91 dayCuret MyriamEVP & Chief Medical OfficerSSale−4.25K$1,082.54−$4.60M−97.8%95 after2 lots
Sep 13, 2021 (view filing)Sep 94 daysRubash Mark JDirectorSSale−1.20K$1,083.16−$1.30M−19.9%4.82K after5 lots
Oct 26, 2021 (view filing)Oct 224 daysDeSantis RobertEVP & Chief Product OfficerSSale−1.01K$339.75−$344.5K−48.1%1.09K after4 lots
Oct 26, 2021 (view filing)Oct 224 daysCuret MyriamEVP & Chief Medical OfficerSSale−6.00K$339.64−$2.04M−95.5%285 after
Oct 26, 2021 (view filing)Oct 224 daysLevy Alan JDirectorSSale−7.50K$339.64−$2.55M−23.6%24.3K after2 lots
Oct 26, 2021 (view filing)Oct 224 daysSamath JamieSVP of FinanceSSale−1.50K$339.67−$510.5K−66.4%762 after6 lots
Oct 26, 2021 (view filing)Oct 251 dayMohr MarshallExecutive VP & CFOSSale−20.5K$339.20−$6.95M−100.0%0 after
Nov 26, 2021 (view filing)Nov 242 daysJohnson Amal MDirectorSSale−7.50K$333.73−$2.50M−41.3%10.7K after
Jan 26, 2022 (view filing)Jan 251 dayDeSantis RobertEVP & Chief Product OfficerSSale−1.41K$261.64−$368.9K−56.4%1.09K after4 lots
Jan 26, 2022 (view filing)Jan 251 dayCuret MyriamEVP & Chief Medical OfficerSSale−6.00K$263.94−$1.58M−95.5%285 after2 lots
Feb 17, 2022 (view filing)Feb 161 dayCuret MyriamEVP & Chief Medical OfficerSSale−2.48K$289.00−$716.1K−87.3%361 after
Mar 2, 2022 (view filing)Mar 11 dayCuret MyriamEVP & Chief Medical OfficerSSale−2.00K$289.96−$579.9K−84.7%361 after
Apr 27, 2022 (view filing)Apr 261 dayCuret MyriamEVP & Chief Medical OfficerSSale−6.00K$252.51−$1.52M−94.3%361 after
Apr 27, 2022 (view filing)Apr 261 dayDeSantis RobertEVP & Chief Product OfficerSSale−1.61K$253.04−$407.6K−20.2%6.36K after4 lots
Jul 27, 2022 (view filing)Jul 261 dayGuthart Gary SPresident & CEOSSale−79.4K$216.30−$17.2M−59.3%54.6K after
Jul 28, 2022 (view filing)Jul 271 dayCuret MyriamEVP & Chief Medical OfficerSSale−9.00K$225.00−$2.02M−97.6%217 after
Aug 4, 2022 (view filing)Aug 31 dayJohnson Amal MDirectorSSale−6.38K$238.04−$1.52M−36.2%11.2K after
Aug 17, 2022 (view filing)5:15 PM ETAug 152 daysLadd Amy LDirectorSSale−600$237.03−$142.2K−45.5%720 after
Sep 9, 2022 (view filing)Sep 81 dayJohnson Amal MDirectorSSale−6.38K$210.76−$1.34M−36.2%11.2K after
Oct 24, 2022 (view filing)Oct 213 daysCuret MyriamEVP & Chief Medical OfficerSSale−8.00K$209.78−$1.68M−97.4%217 after2 lots
Oct 24, 2022 (view filing)Oct 213 daysGuthart Gary SPresident & CEOSSale−44.2K$210.84−$9.32M−65.5%23.3K after
Nov 2, 2022 (view filing)Nov 11 dayCuret MyriamEVP & Chief Medical OfficerSSale−8.00K$250.06−$2.00M−97.4%217 after2 lots
Nov 9, 2022 (view filing)Nov 81 dayJohnson Amal MDirectorSSale−6.38K$239.36−$1.53M−36.2%11.2K after
Jan 30, 2023 (view filing)Jan 273 daysDeSantis RobertEVP & Chief Product OfficerSSale−1.63K$250.00−$407.3K−19.4%6.77K after2 lots
Feb 7, 2023 (view filing)Feb 61 dayRosa David J.EVP Chief Strategy & Growth OfSSale−45.0K$250.53−$11.3M−26.4%125.4K after
Feb 14, 2023 (view filing)Feb 131 dayWidman FredrikVP Corporate ControllerSSale−1.31K$246.09−$321.6K−46.7%1.49K after
Feb 14, 2023 (view filing)Feb 131 dayMohr MarshallExecutive VP Global Business SSSale−33.2K$245.61−$8.17M−61.6%20.8K after
Feb 16, 2023 (view filing)Feb 16Same dayDeSantis RobertEVP & Chief Product OfficerSSale−1.97K$240.77−$474.6K−23.6%6.37K after
Feb 16, 2023 (view filing)Feb 16Same dayCuret MyriamEVP & Chief Medical OfficerSSale−1.12K$240.77−$270.6K−77.5%327 after
Feb 16, 2023 (view filing)Feb 16Same dayWidman FredrikVP Corporate ControllerSSale−116$240.77−$27.9K−6.7%1.60K after
Mar 1, 2023 (view filing)Mar 1Same dayCuret MyriamEVP & Chief Medical OfficerSSale−1.25K$228.47−$286.3K−39.1%1.95K after
Apr 24, 2023 (view filing)Apr 213 daysCuret MyriamEVP & Chief Medical OfficerSSale−9.62K$299.76−$2.88M−96.7%327 after4 lots
Apr 24, 2023 (view filing)Apr 213 daysBarratt Craig HDirectorSSale−6.00K$297.92−$1.79M−100.0%0 after3 lots
Apr 24, 2023 (view filing)Apr 213 daysDeSantis RobertEVP & Chief Product OfficerSSale−8.62K$297.92−$2.57M−55.0%7.07K after7 lots
Apr 24, 2023 (view filing)Apr 213 daysWidman FredrikVP Corporate ControllerSSale−630$297.87−$187.7K−22.0%2.23K after
Apr 24, 2023 (view filing)Apr 213 daysRubash Mark JDirectorSSale−8.13K$297.93−$2.42M−35.2%15.0K after15 lots
Apr 24, 2023 (view filing)Apr 213 daysRubash Mark JDirectorSSale−1.68K$297.92−$501.4K−10.1%15.0K after5 lots
Apr 24, 2023 (view filing)Apr 21-243 daysRosa David J.EVP Chief Strategy & Growth OfSSale−81.6K$298.56−$24.4M−34.4%155.7K after2 lots
May 1, 2023 (view filing)Apr 283 daysRubash Mark JDirectorSSale−7.32K$300.00−$2.20M−32.1%15.5K after7 lots
May 2, 2023 (view filing)May 11 dayBarratt Craig HDirectorSSale−2.00K$306.00−$612.0K−100.0%0 after